{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:40:41Z","timestamp":1777513241444,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2012CB518402"],"award-info":[{"award-number":["2012CB518402"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major Special Project Major Creation of New Drugs","award":["2009ZX09501-304"],"award-info":[{"award-number":["2009ZX09501-304"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbrc.2018.06.110","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T18:21:03Z","timestamp":1530987663000},"page":"1011-1019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Ophiopogonin D alleviates cardiac hypertrophy in rat by upregulating CYP2J3 in\u00a0vitro and suppressing inflammation in\u00a0vivo"],"prefix":"10.1016","volume":"503","author":[{"given":"Yuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4836-4893","authenticated-orcid":false,"given":"Xiaoyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zengchun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2018.06.110_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIR.0b013e3182456d46","article-title":"Executive summary: heart disease and stroke statistics\u20132012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1016\/j.bbrc.2018.06.110_bib2","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/00005344-199117002-00003","article-title":"G.t. Cooper, Signals for cardiac muscle hypertrophy in hypertension","volume":"17","author":"Kent","year":"1991","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.06.110_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbrc.2018.06.110_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.genom.1.1.179","article-title":"From the sarcomere to the nucleus: role of genetics and signaling in structural heart disease","volume":"1","author":"Nicol","year":"2000","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"10.1016\/j.bbrc.2018.06.110_bib5","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0895-7061(96)00199-9","article-title":"Comparison of target organ damage in renovascular and essential hypertension","volume":"9","author":"Losito","year":"1996","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbrc.2018.06.110_bib6","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system, American journal of physiology","volume":"292","author":"Mehta","year":"2007","journal-title":"Cell Physiol."},{"key":"10.1016\/j.bbrc.2018.06.110_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jmb.2007.10.006","article-title":"Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB","volume":"375","author":"Gupta","year":"2008","journal-title":"JMB (J. Mol. Biol.)"},{"key":"10.1016\/j.bbrc.2018.06.110_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.yjmcc.2006.07.006","article-title":"Regulating the regulator: NF-kappaB signaling in heart","volume":"41","author":"Hall","year":"2006","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2018.06.110_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ndt\/16.suppl_1.27","article-title":"Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice","volume":"16","author":"Ruiz-Ortega","year":"2001","journal-title":"Nephrol., Dial., Transplant.: Off. Publ. Eur. Dial. Transplant Assoc. Eur. Renal Assoc."},{"key":"10.1016\/j.bbrc.2018.06.110_bib10","doi-asserted-by":"crossref","first-page":"840650","DOI":"10.1155\/2014\/840650","article-title":"An overview of systematic reviews of shenmai injection for healthcare","volume":"2014","author":"Lu","year":"2014","journal-title":"Evidence-Based Complement. Alternat. Med.: eCAM"},{"key":"10.1016\/j.bbrc.2018.06.110_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jpba.2010.02.016","article-title":"Characterization of homoisoflavonoids in different cultivation regions of Ophiopogon japonicus and related antioxidant activity","volume":"52","author":"Lin","year":"2010","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.bbrc.2018.06.110_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/acm.2010.0354","article-title":"Shenmai injection for chronic pulmonary heart disease: a systematic review and meta-analysis","volume":"17","author":"Li","year":"2011","journal-title":"J.\u00a0Alternative Compl. Med."},{"key":"10.1016\/j.bbrc.2018.06.110_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpba.2010.12.015","article-title":"HPLC\/MS\/MS for quantification of two types of neurotransmitters in rat brain and application: myocardial ischemia and protection of Sheng-Mai-San","volume":"55","author":"Xu","year":"2011","journal-title":"J.\u00a0Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.bbrc.2018.06.110_bib14","first-page":"209","article-title":"Study on the protective effect of shengmai san (see text) on the myocardium in the type 2 diabetic cardiomyopathy model rat","volume":"31","author":"Ni","year":"2011","journal-title":"J.\u00a0Trad. Chin. Med.\u00a0= Chung i tsa chih ying wen pan"},{"key":"10.1016\/j.bbrc.2018.06.110_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1142\/S0192415X06003849","article-title":"Sheng-mai-san reduces adriamycin-induced cardiomyopathy in rats","volume":"34","author":"You","year":"2006","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.bbrc.2018.06.110_bib16","first-page":"2956","article-title":"Effects of Shenmai injection on afterdepolarization and triggered activities in left ventricular papillary muscle in rat cardiac hypertrophy","volume":"39","author":"Jiao","year":"2014","journal-title":"Zhongguo Zhong yao za zhi\u00a0= Zhongguo zhongyao zazhi\u00a0= China J. Chin. Mater. Med."},{"key":"10.1016\/j.bbrc.2018.06.110_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jchromb.2007.11.020","article-title":"Simultaneous determination of ginsenoside Rg1, Re, Rd, Rb1 and ophiopogonin D in rat plasma by liquid chromatography\/electrospray ionization mass spectrometric method and its application to pharmacokinetic study of 'SHENMAI' injection","volume":"862","author":"Xia","year":"2008","journal-title":"J.\u00a0Chromatogr. B, Analytical Technol. Biomed. Life Sci."},{"key":"10.1016\/j.bbrc.2018.06.110_bib18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.fitote.2012.05.011","article-title":"Anti-inflammatory homoisoflavonoids from the tuberous roots of Ophiopogon japonicus","volume":"83","author":"Li","year":"2012","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bbrc.2018.06.110_bib19","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1248\/bpb.28.1234","article-title":"Anti-inflammatory activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents","volume":"28","author":"Kou","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bbrc.2018.06.110_bib20","volume":"vol. 21","author":"Cheng","year":"2016"},{"key":"10.1016\/j.bbrc.2018.06.110_bib21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bcp.2013.11.015","article-title":"Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy","volume":"87","author":"El-Sherbeni","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2018.06.110_bib22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/aps.2015.146","article-title":"Ophiopogonin D maintains Ca2+ homeostasis in rat cardiomyocytes in\u00a0vitro by upregulating CYP2J3\/EETs and suppressing ER stress","volume":"37","author":"You","year":"2016","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.bbrc.2018.06.110_bib23","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1074\/jbc.M406618200","article-title":"Impaired Ca2+ store functions in skeletal and cardiac muscle cells from sarcalumenin-deficient mice","volume":"280","author":"Yoshida","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2018.06.110_bib24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.bbrc.2005.06.186","article-title":"Mechanical stress-dependent transcriptional regulation of sarcolipin gene in the rodent atrium","volume":"334","author":"Shimura","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.06.110_bib25","first-page":"737","article-title":"Gene silencing in mammals by small interfering RNAs, Nature reviews","volume":"3","author":"McManus","year":"2002","journal-title":"Genetics"},{"key":"10.1016\/j.bbrc.2018.06.110_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/418244a","article-title":"RNA interference","volume":"418","author":"Hannon","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2018.06.110_bib27","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1161\/CIRCULATIONAHA.107.711317","article-title":"Calsarcin-1 protects against angiotensin-II induced cardiac hypertrophy","volume":"116","author":"Frank","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2018.06.110_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0031-6997(24)01434-0","article-title":"Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases","volume":"52","author":"Kim","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbrc.2018.06.110_bib29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/01.RES.85.7.643","article-title":"The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?","volume":"85","author":"Dostal","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2018.06.110_bib30","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1006\/jmcc.2002.2076","article-title":"Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia\/reperfusion dysfunction, and heart failure","volume":"34","author":"Booz","year":"2002","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2018.06.110_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.regpep.2004.04.004","article-title":"Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy","volume":"120","author":"Baker","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bbrc.2018.06.110_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.yjmcc.2003.11.004","article-title":"PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats","volume":"36","author":"Diep","year":"2004","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbrc.2018.06.110_bib33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/01.HYP.35.1.360","article-title":"Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes","volume":"35","author":"Mervaala","year":"2000","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"10.1016\/j.bbrc.2018.06.110_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/01.HYP.35.1.193","article-title":"NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats","volume":"35","author":"Muller","year":"2000","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"10.1016\/j.bbrc.2018.06.110_bib35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.HYP.36.2.282","article-title":"Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage","volume":"36","author":"Muller","year":"2000","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"10.1016\/j.bbrc.2018.06.110_bib36","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/01.ATV.0000164624.00099.e7","article-title":"A\u00a0new cellular signaling mechanism for angiotensin II activation of NF-kappaB: an IkappaB-independent, RSK-mediated phosphorylation of p65","volume":"25","author":"Zhang","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2018.06.110_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cytogfr.2008.04.005","article-title":"Crosstalk via the NF-kappaB signaling system","volume":"19","author":"Basak","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bbrc.2018.06.110_bib38","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1073\/pnas.111155798","article-title":"Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes","volume":"98","author":"Purcell","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2018.06.110_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.freeradbiomed.2010.10.711","article-title":"Inhibition of nuclear factor kappaB regresses cardiac hypertrophy by modulating the expression of extracellular matrix and adhesion molecules","volume":"50","author":"Kumar","year":"2011","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.bbrc.2018.06.110_bib40","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bbrc.2004.07.048","article-title":"Activation of nuclear factor-kappaB and its proinflammatory mediator cascade in the infarcted rat heart","volume":"321","author":"Lu","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2018.06.110_bib41","first-page":"41","article-title":"Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heart","volume":"143","author":"Sun","year":"2004","journal-title":"J.\u00a0Lab. Clin. Med."},{"key":"10.1016\/j.bbrc.2018.06.110_bib42","doi-asserted-by":"crossref","first-page":"H336","DOI":"10.1152\/ajpheart.01307.2005","article-title":"ANG II-induced cardiac molecular and cellular events: role of aldosterone, American journal of physiology","volume":"291","author":"Zhao","year":"2006","journal-title":"Heart Circ. Physiol."},{"key":"10.1016\/j.bbrc.2018.06.110_bib43","doi-asserted-by":"crossref","first-page":"29109","DOI":"10.1074\/jbc.M802143200","article-title":"Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta","volume":"283","author":"Smeets","year":"2008","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18314220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X18314220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:26:40Z","timestamp":1757762800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X18314220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0006291X18314220"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.06.110","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ophiopogonin D alleviates cardiac hypertrophy in rat by upregulating CYP2J3 in\u00a0vitro and suppressing inflammation in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2018.06.110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}